Squarepoint
FPRX

Squarepoint’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Squarepoint’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,726
Closed -$1.32M – 3870
2020
Q4 		$1.32M Buy
77,726
+102
+0.1% +$1.28K 0.01% 1161
2020
Q3 		$365K Buy
77,624
+58,460
+305% +$297K ﹤0.01% 1657
2020
Q2 		$117K Sell
19,164
-9,412
-33% -$38.8K ﹤0.01% 1981
2020
Q1 		$65K Buy
28,576
+5,076
+22% +$21.5K ﹤0.01% 1700
2019
Q4 		$108K Sell
23,500
-184,323
-89% -$730K ﹤0.01% 2336
2019
Q3 		$805K Buy
207,823
+173,581
+507% +$952K 0.01% 1372
2019
Q2 		$206K Buy
34,242
+17,447
+104% +$167K ﹤0.01% 2097
2019
Q1 		$225K Sell
16,795
-57,645
-77% -$658K ﹤0.01% 1899
2018
Q4 		$692K Sell
74,440
-24,115
-24% -$287K 0.01% 1077
2018
Q3 		$1.37M Buy
98,555
+59,255
+151% +$881K 0.02% 851
2018
Q2 		$621K Buy
+39,300
New +$686K 0.01% 1090
2018
Q1 		– Sell
-24,118
Closed -$529K – 2339
2017
Q4 		$529K Buy
+24,118
New +$776K 0.01% 1175
2017
Q2 		– Sell
-16,896
Closed -$611K – 1923
2017
Q1 		$611K Buy
16,896
+2,614
+18% +$115K 0.02% 776
2016
Q4 		$716K Buy
+14,282
New +$750K 0.03% 642
2016
Q2 		– Sell
-6,159
Closed -$250K – 1427
2016
Q1 		$250K Sell
6,159
-441
-7% -$15.2K 0.02% 908
2015
Q4 		$274K Buy
+6,600
New +$221K 0.03% 840

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Squarepoint's FPRX Position: Q1 2021 in Review

Squarepoint sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 77,726 shares — an estimated $1.32M sold.

Squarepoint first reported a position in FPRX in Q4 2015 and held it in 16 quarters. The position peaked at $1.37M in Q3 2018. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Squarepoint reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 77,726 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $1.32M.
  • Squarepoint first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 16 quarters.
  • Squarepoint's Five Prime Therapeutics, Inc. position peaked at $1.37M in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.